These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2826101)

  • 21. The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial asthma.
    Williams AJ; Stableforth D
    Eur J Respir Dis Suppl; 1986; 147():340-3. PubMed ID: 3021502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled nedocromil sodium as additional treatment to high dose inhaled corticosteroids in the management of bronchial asthma.
    Svendsen UG; Jørgensen H
    Eur Respir J; 1991 Sep; 4(8):992-9. PubMed ID: 1664346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nedocromil sodium in the treatment of non-allergic subjects with chronic obstructive pulmonary disease.
    de Jong JW; Postma DS; van der Mark TW; Koëter GH
    Thorax; 1994 Oct; 49(10):1022-4. PubMed ID: 7974297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term management of reversible obstructive airways disease in adults.
    Lurie A; Vlastos FD; Dusser DJ; Strauch G; Marsac J
    Lung; 1990; 168 Suppl():154-67. PubMed ID: 1974671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of nedocromil sodium in mast-cell-dependent reactions in the rat.
    Riley PA; Mather ME; Keogh RW; Eady RP
    Int Arch Allergy Appl Immunol; 1987; 82(1):108-10. PubMed ID: 3026967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma.
    Edwards AM; Stevens MT
    Eur Respir J; 1993 Jan; 6(1):35-41. PubMed ID: 8381089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine-induced bronchoconstriction: comparison between nedocromil sodium and sodium cromoglycate.
    Crimi N; Palermo F; Oliveri R; Cacopardo B; Vancheri C; Mistretta A
    Eur J Respir Dis Suppl; 1986; 147():258-62. PubMed ID: 3021497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of nedocromil sodium (Tilade) on the activation of human eosinophils and neutrophils and the release of histamine from mast cells.
    Moqbel R; Cromwell O; Walsh GM; Wardlaw AJ; Kurlak L; Kay AB
    Allergy; 1988 May; 43(4):268-76. PubMed ID: 2455454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nedocromil sodium: a new therapeutic option for reversible obstructive airways disease.
    Orr TS
    Br J Clin Pract Suppl; 1987 Nov; 53():9-12. PubMed ID: 2849475
    [No Abstract]   [Full Text] [Related]  

  • 30. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age.
    Muijsers RB; Noble S
    Paediatr Drugs; 2002; 4(2):123-39. PubMed ID: 11888359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicentre double-blind group comparative trial of two dose levels of nedocromil sodium and placebo in the management of perennial extrinsic asthma.
    Greco DB; Negreiros EB; Chaieb JA; Ferreira-Lima P; Croce J
    Eur J Respir Dis Suppl; 1986; 147():323-6. PubMed ID: 3021499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withdrawal of inhaled corticosteroid under cover of nedocromil sodium.
    Paananen M; Karakorpi T; Kreus KE
    Eur J Respir Dis Suppl; 1986; 147():330-5. PubMed ID: 3021500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nedocromil sodium 2% ophthalmic solution (Tilavist(TM)) A new topical treatment for ocular allergic inflammation.
    Knottnerus IG; Scott CN; Riley PA
    Ocul Immunol Inflamm; 1993; 1(1-2):27-30. PubMed ID: 22827188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind group comparative trial of nedocromil sodium and placebo in the management of bronchial asthma.
    Fairfax AJ; Allbeson M
    J Int Med Res; 1988; 16(3):216-24. PubMed ID: 2842206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments.
    Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Pearce FL
    Eur J Respir Dis Suppl; 1986; 147():223-6. PubMed ID: 2429855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differential effects of nedocromil sodium and sodium cromoglycate on the secretory response of rabbit peritoneal neutrophils.
    Bradford PG; Rubin RP
    Eur J Respir Dis Suppl; 1986; 147():238-40. PubMed ID: 3021494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B; Faulds D
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monkeys infected with Ascaris suum (a new in vivo model of airway disease): protective effect of nedocromil sodium and sodium cromoglycate against bronchial antigen challenge.
    Jackson DM; Eady RP
    Eur J Respir Dis Suppl; 1986; 147():202-5. PubMed ID: 3021491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nedocromil: a new agent for the treatment of asthma.
    Keenan JM
    Am Fam Physician; 1994 Oct; 50(5):1059-64. PubMed ID: 7942403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nedocromil sodium inhibits IgE-dependent activation of rat macrophages and platelets as measured by schistosome killing, chemiluminescence and enzyme release.
    Joseph M; Capron A; Thorel T; Tonnel AB
    Eur J Respir Dis Suppl; 1986; 147():220-2. PubMed ID: 3021493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.